NR1H3 and metabolic dysfunction-associated steatotic liver disease: The hepatic expression of LXRα and its lipogenic and inflammatory targets was evaluated in 43 patients with NAFLD, 44 with chronic HCV infection and in 22 with histologically normal liver.